{"country":"Serbia","iso2":"RS","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":9,"new_today":0,"on_pages":9,"full_list":[],"page":1,"pages":1,"per_page":500,"html":"https://worldwide-corruption.com/database/serbia/findings/fcpa-pattern/","records":[{"code":"W-04603","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB~ · RS · WB P129539 · Second Serbia Health Project","buyer":"","amount":14646127.04,"currency":null,"records":3,"found":"2026-10-04","refs":["WB-1695512","WB-1695496","WB-1672210","2012-08-07"],"id":"W-04603","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04603/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04603/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'PHARMACIA ~0.73' «MAGNA PHARMACIA» ↔ SEC PFE (CIK 78003, PFIZER INC): 3 non-competitive contracts at the buyer «WB P129539 · Second Serbia Health Project», 14,646,127 USD (≈ $14,646,127); method direct (Direct Selection); OCID WB-1695512, WB-1695496, WB-1672210; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer).","facts":[["Company / subject","PFE · SUB~ · RS · WB P129539 · Second Serbia Health Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","14,646,127",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-04603",null],["Reference","WB-1695512",null],["Reference","WB-1695496",null],["Reference","WB-1672210",null],["Reference","2012-08-07",null]],"summary":"looks like a subsidiary 'PHARMACIA ~0.73' «MAGNA PHARMACIA» ↔ SEC PFE (CIK 78003, PFIZER INC): 3 non-competitive contracts at the buyer «WB P129539 · Second Serbia Health Project», 14,646,127 USD (≈ $14,646,127); method direct (Direct Selection); OCID WB-1695512, WB-1695496, WB-1672210; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer)","entity":"35ee8461"},{"code":"W-04549","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"MCO · SUB · RS · WB P163673 · Tax Administration Modernization Project","buyer":"","amount":1125463.84,"currency":null,"records":3,"found":"2026-10-04","refs":["WB-1871934","WB-1819248","WB-1700962"],"id":"W-04549","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04549/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04549/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «BUREAU VAN DIJK EDITIONS ELECTRONIQUES SARL (+ more 1 legal entities of the family)» ↔ SEC MCO (CIK 1059556, MOODYS CORP /DE/): 3 non-competitive contracts at the buyer «WB P163673 · Tax Administration Modernization Project», 1,125,464 USD (≈ $1,125,464); method direct (Direct Selection); OCID WB-1871934, WB-1819248, WB-1700962.","facts":[["Company / subject","MCO · SUB · RS · WB P163673 · Tax Administration Modernization Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,125,464",null],["Records behind the indicator","3",null],["Found","4 October 2026",null],["Code","W-04549",null],["Reference","WB-1871934",null],["Reference","WB-1819248",null],["Reference","WB-1700962",null]],"summary":"subsidiary/issuer «BUREAU VAN DIJK EDITIONS ELECTRONIQUES SARL (+ more 1 legal entities of the family)» ↔ SEC MCO (CIK 1059556, MOODYS CORP /DE/): 3 non-competitive contracts at the buyer «WB P163673 · Tax Administration Modernization Project», 1,125,464 USD (≈ $1,125,464); method direct (Direct Selection); OCID WB-1871934, WB-1819248, WB-1700962","entity":"42944b01"},{"code":"W-04557","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB~ · RS · WB P173892 · Serbia Emergency COVID-19 Response Project","buyer":"","amount":439152.0,"currency":null,"records":1,"found":"2026-10-04","refs":["WB-1842192","2012-08-07"],"id":"W-04557","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04557/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04557/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'PHARMACIA ~0.73' «MAGNA PHARMACIA» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «WB P173892 · Serbia Emergency COVID-19 Response Project», 439,152 USD (≈ $439,152); method direct (Direct Selection); OCID WB-1842192; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase.","facts":[["Company / subject","PFE · SUB~ · RS · WB P173892 · Serbia Emergency COVID-19 Response Project",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","439,152",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-04557",null],["Reference","WB-1842192",null],["Reference","2012-08-07",null]],"summary":"looks like a subsidiary 'PHARMACIA ~0.73' «MAGNA PHARMACIA» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «WB P173892 · Serbia Emergency COVID-19 Response Project», 439,152 USD (≈ $439,152); method direct (Direct Selection); OCID WB-1842192; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase","entity":"c48f2fc3"},{"code":"W-04542","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"CCEP · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets","buyer":"","amount":156966.0,"currency":null,"records":5,"found":"2026-10-04","refs":["WB-1885434","WB-1882232","WB-1882234","WB-1864952","WB-1835665"],"id":"W-04542","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04542/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04542/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «ERNST & YOUNG» ↔ SEC CCEP (CIK 1650107, COCA-COLA EUROPACIFIC PARTNERS plc): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665.","facts":[["Company / subject","CCEP · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","156,966",null],["Records behind the indicator","5",null],["Found","4 October 2026",null],["Code","W-04542",null],["Reference","WB-1885434",null],["Reference","WB-1882232",null],["Reference","WB-1882234",null],["Reference","WB-1864952",null],["Reference","WB-1835665",null]],"summary":"subsidiary/issuer «ERNST & YOUNG» ↔ SEC CCEP (CIK 1650107, COCA-COLA EUROPACIFIC PARTNERS plc): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665","entity":"5d7838b2"},{"code":"W-04544","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"AMUB · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets","buyer":"","amount":156966.0,"currency":null,"records":5,"found":"2026-10-04","refs":["WB-1885434","WB-1882232","WB-1882234","WB-1864952","WB-1835665"],"id":"W-04544","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04544/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04544/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «ERNST & YOUNG» ↔ SEC AMUB (CIK 1114446, UBS AG): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665.","facts":[["Company / subject","AMUB · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","156,966",null],["Records behind the indicator","5",null],["Found","4 October 2026",null],["Code","W-04544",null],["Reference","WB-1885434",null],["Reference","WB-1882232",null],["Reference","WB-1882234",null],["Reference","WB-1864952",null],["Reference","WB-1835665",null]],"summary":"subsidiary/issuer «ERNST & YOUNG» ↔ SEC AMUB (CIK 1114446, UBS AG): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665","entity":"ef95453b"},{"code":"W-04541","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"NCNA · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets","buyer":"","amount":156966.0,"currency":null,"records":5,"found":"2026-10-04","refs":["WB-1885434","WB-1882232","WB-1882234","WB-1864952","WB-1835665"],"id":"W-04541","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04541/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04541/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «ERNST & YOUNG» ↔ SEC NCNA (CIK 1709626, NuCana plc): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665.","facts":[["Company / subject","NCNA · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","156,966",null],["Records behind the indicator","5",null],["Found","4 October 2026",null],["Code","W-04541",null],["Reference","WB-1885434",null],["Reference","WB-1882232",null],["Reference","WB-1882234",null],["Reference","WB-1864952",null],["Reference","WB-1835665",null]],"summary":"subsidiary/issuer «ERNST & YOUNG» ↔ SEC NCNA (CIK 1709626, NuCana plc): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665","entity":"6de72632"},{"code":"W-04543","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GCL · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets","buyer":"","amount":156966.0,"currency":null,"records":5,"found":"2026-10-04","refs":["WB-1885434","WB-1882232","WB-1882234","WB-1864952","WB-1835665"],"id":"W-04543","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04543/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04543/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «ERNST & YOUNG» ↔ SEC GCL (CIK 2002045, GCL Global Holdings Ltd): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665.","facts":[["Company / subject","GCL · SUB · RS · WB P176069 · Catalyzing Long Term Finance through Capital Markets",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","156,966",null],["Records behind the indicator","5",null],["Found","4 October 2026",null],["Code","W-04543",null],["Reference","WB-1885434",null],["Reference","WB-1882232",null],["Reference","WB-1882234",null],["Reference","WB-1864952",null],["Reference","WB-1835665",null]],"summary":"subsidiary/issuer «ERNST & YOUNG» ↔ SEC GCL (CIK 2002045, GCL Global Holdings Ltd): 5 non-competitive contracts at the buyer «WB P176069 · Catalyzing Long Term Finance through Capital Markets», 156,966 USD (≈ $156,966); method direct (Direct Selection); OCID WB-1885434, WB-1882232, WB-1882234, WB-1864952, WB-1835665","entity":"bc6f86ae"},{"code":"W-04762","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"ENSG · SUB~ · RS · WB P077675 · Health Project (Serbia)","buyer":"","amount":24290.66,"currency":null,"records":2,"found":"2026-10-04","refs":["WB-1254848","WB-1254785","2021-10-06"],"id":"W-04762","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04762/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04762/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: ENSG · SUB~ · RS · WB P077675 · Health Project (Serbia), 24,291.","facts":[["Company / subject","ENSG · SUB~ · RS · WB P077675 · Health Project (Serbia)",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","24,291",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-04762",null],["Reference","WB-1254848",null],["Reference","WB-1254785",null],["Reference","2021-10-06",null]],"summary":null,"entity":"ae1fac89"},{"code":"W-04763","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"WELL · SUB~ · RS · WB P077675 · Health Project (Serbia)","buyer":"","amount":24290.66,"currency":null,"records":2,"found":"2026-10-04","refs":["WB-1254848","WB-1254785","2021-10-06"],"id":"W-04763","html":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04763/","json":"https://worldwide-corruption.com/record/serbia/findings/fcpa-pattern/W-04763/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer” computed from public data: WELL · SUB~ · RS · WB P077675 · Health Project (Serbia), 24,291.","facts":[["Company / subject","WELL · SUB~ · RS · WB P077675 · Health Project (Serbia)",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","24,291",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-04763",null],["Reference","WB-1254848",null],["Reference","WB-1254785",null],["Reference","2021-10-06",null]],"summary":null,"entity":"afb9fa40"}]}